Although a Causal link between the secretion of GM-CSF by tumor cells and the clinical outcome of specific cancer types is yet to be established, the plethora of literature suggests that GM-CSF behaves as a double-edged sword in cancer. This evidence concerns the gene CSF2 and neoplasm.